HALO
$109.86+2.73%
as of close, Oct 2, 2026
☾ AH $109.86 +2.73%
Halozyme Therapeutics Inc.Stock · Health CareNasdaq Composite 0.02%Russell 3000 0.01%Russell 1000 0.01%US Stock Market 0.01%
HALO financial statements
The full income statement, balance sheet, and cash-flow statement for Halozyme Therapeutics Inc. (HALO), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 126.7M2024-09 127.2M2024-12 123.2M2025-03 123.2M2025-06 117.0M2025-09 117.6M2025-12 118.0M2026-03 118.6M2026-06 113.5M-10.4% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 1.40B+37.6% | 1.02B+22.4% | 829M+25.6% | 660M+48.9% | 443M+65.7% | |
| Cost of revenue | 229M+43.5% | 159M-17.1% | 192M+38.1% | 139M+71.1% | 81.4M+87.7% | |
| Research & development | 81.5M+3.1% | 79.0M+3.5% | 76.4M+14.6% | 66.6M+86.7% | 35.7M+4.2% | |
| Selling, general & administrative | 207M+34.2% | 154M+3.5% | 149M+3.9% | 144M+185.2% | 50.3M+10.0% | |
| Amortization of intangibles | 76.7M+7.9% | 71.0M-3.7% | 73.8M+71.0% | 43.1M | 0.00 | |
| Operating income | 469M-15.0% | 551M+63.4% | 338M+26.2% | 268M-3.0% | 276M+91.3% | |
| Interest expense | 18.1M+0.2% | 18.1M-3.6% | 18.8M+10.7% | 16.9M+125.2% | 7.53M-63.1% | |
| Other non-operating income | 21.5M-9.6% | 23.8M+45.6% | 16.3M+1459.9% | 1.05M-5.1% | 1.10M-79.7% | |
| Pre-tax income | 467M-16.2% | 557M+59.9% | 348M+39.9% | 249M+0.2% | 249M+92.2% | |
| Income tax | 150M+32.7% | 113M+69.4% | 66.7M+42.6% | 46.8M+130.3% | -154M-71156.2% | |
| Net income | 317M-28.6% | 444M+57.7% | 282M+39.3% | 202M-49.8% | 403M+212.0% | |
| $2.56-25.4% | $3.43+63.3% | $2.10+45.8% | $1.44-47.4% | $2.74+201.1% | ||
| EPS (basic) | $2.64-24.6% | $3.50+64.3% | $2.13+43.9% | $1.48-48.3% | $2.86+201.1% | |
| Weighted-avg shares (basic) | 120M-5.5% | 127M-3.9% | 132M-3.6% | 137M-2.7% | 141M+3.3% | |
| Weighted-avg shares (diluted) | 124M-4.3% | 129M-3.6% | 134M-4.6% | 141M-4.2% | 147M+3.8% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 825M-24.0% | 1.09B+45.4% | 746M+1.0% | 739M-20.2% | 926M+67.0% | ||
| Cash & equivalents | 134M+15.5% | 116M-2.1% | 118M-49.5% | 234M+97.3% | 119M-19.6% | |
| Accounts receivable | 426M+47.9% | 288M+23.6% | 233M+24.8% | 187M+105.5% | 91.0M-6.9% | |
| Inventory | 176M+24.4% | 142M+11.2% | 128M+27.4% | 100M+85.7% | 53.9M-11.3% | |
| Prepaid expenses | 64.6M+65.9% | 39.0M-19.9% | 48.6M+8.0% | 45.0M+11.2% | 40.5M+43.2% | |
| 2.53B+22.4% | 2.06B+19.1% | 1.73B-5.9% | 1.84B+66.7% | 1.10B+90.4% | ||
| Property, plant & equipment | 44.4M+8.8% | 40.9M+7.2% | 38.1M+8.6% | 35.1M+416.9% | 6.79M-6.9% | |
| Operating lease right-of-use | 37.7M+10.3% | 34.2M-7.2% | 36.8M-9.0% | 40.5M+1920.4% | 2.00M-39.3% | |
| Goodwill | 580M+39.2% | 417M+0.0% | 417M+1.9% | 409M | 0.00 | |
| Intangible assets | 981M+144.2% | 402M-15.0% | 473M-13.5% | 547M | 0.00 | |
| Deferred tax assets | 0.00-100.0% | 3.85M-12.1% | 4.39M-90.1% | 44.4M-71.4% | 155M | |
| 177M+27.3% | 139M+23.7% | 112M-14.0% | 131M+11.6% | 117M-72.2% | ||
| Accounts payable | 20.9M+103.9% | 10.2M-13.3% | 11.8M-33.2% | 17.7M+1048.2% | 1.54M-20.1% | |
| Accrued liabilities | 156M+21.2% | 129M+28.0% | 101M+0.9% | 99.8M+308.2% | 24.4M+19.3% | |
| Deferred revenue | — | — | — | 3.25M+85.9% | 1.75M+0.0% | |
| Short-term & current debt | 0.00 | 0.00 | 0.00-100.0% | 13.3M-85.1% | 89.4M-77.5% | |
| 2.48B+45.7% | 1.70B+3.0% | 1.65B-1.3% | 1.67B | — | ||
| Long-term debt | 2.14B+42.3% | 1.51B+0.4% | 1.50B+0.4% | 1.49B+89.6% | 787M | |
| Deferred revenue (non-current) | — | — | — | 2.25M-10.9% | 2.53M-37.2% | |
| Operating lease liability (total) | 34.6M+12.6% | 30.7M-4.6% | 32.2M-7.4% | 34.8M+1133.6% | 2.82M-42.1% | |
| Deferred tax liabilities | 42.9M | 0.00 | 0.00 | — | 0.00 | |
| Other non-current liabilities | 114M+107.9% | 54.8M+45.2% | 37.7M+15.4% | 32.7M+5908.5% | 544K-84.3% | |
| 48.8M-86.6% | 364M+334.1% | 83.8M-50.6% | 170M-13.8% | 197M+30.4% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 118K-4.1% | 123K-3.1% | 127K-5.9% | 135K-2.2% | 138K+2.2% | |
| Additional paid-in capital | 12.0M | 0.00-100.0% | 2.41M-91.2% | 27.4M-89.3% | 256M-59.0% | |
| Retained earnings | 54.8M-84.8% | 360M+297.4% | 90.5M-36.8% | 143M+343.1% | -58.9M+87.6% | |
| Accumulated other comprehensive income | -18.1M-572.5% | 3.83M+141.3% | -9.28M-906.3% | -922K-48.7% | -620K-2918.2% | |
| Total liabilities & equity | 2.53B+22.4% | 2.06B+19.1% | 1.73B-5.9% | 1.84B+66.7% | 1.10B+90.4% | |
| Common shares issued | 118M-4.3% | 123M-2.9% | 127M-6.2% | 135M-1.7% | 137M+1.8% | |
| Common shares outstanding | 118M-4.3% | 123M-2.9% | 127M-6.2% | 135M-1.7% | 137M+1.8% | |
| Shares outstanding (cover) | 118M-4.2% | 123M-2.9% | 127M-6.3% | 135M-1.7% | 138M+1.8% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 652M+36.0% | 479M+23.3% | 389M+61.8% | 240M-19.8% | 299M+440.0% | ||
| Depreciation & amortization | 11.4M+11.0% | 10.3M-7.4% | 11.1M+70.7% | 6.49M+116.6% | 3.00M-8.7% | |
| Intangible amortization | 76.7M+7.9% | 71.0M-3.7% | 73.8M+71.0% | 43.1M | 0.00 | |
| Share-based compensation | 51.6M+18.9% | 43.4M+18.5% | 36.6M+50.1% | 24.4M+17.2% | 20.8M+21.0% | |
| Change in receivables | 128M+72.5% | 74.2M+2123.6% | 3.34M-96.0% | 83.9M+1342.6% | -6.75M-117.6% | |
| Change in inventory | -2.55M-103.8% | 67.4M+150.6% | 26.9M+53.8% | 17.5M+337.2% | -7.37M-123.5% | |
| Other operating activities | — | 0.00 | 0.00+100.0% | -227K-7466.7% | -3.00K+76.9% | |
| -546M-107.8% | -263M-171.1% | -96.9M+80.1% | -487M-19.9% | -406M-618.5% | ||
| Capital expenditure | 6.97M-34.8% | 10.7M-30.1% | 15.3M+218.0% | 4.81M+230.1% | 1.46M-41.8% | |
| Free cash flow | 645M+37.6% | 468M+25.5% | 373M+58.6% | 235M-21.0% | 298M+462.8% | |
| Acquisitions | 726M | 0.00 | 0.00-100.0% | 999M | 0.00 | |
| Proceeds from sale of PP&E | — | 0.00 | 0.00-100.0% | 26.0M | 0.00-100.0% | |
| -85.2M+61.1% | -219M+46.4% | -408M-212.6% | 362M+365.4% | 77.9M+173.3% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 785M | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 342M+36.9% | 250M-37.9% | 402M+101.2% | 200M-42.9% | 350M+133.2% | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 20.6M+916.3% | -2.52M+97.8% | -116M-200.7% | 115M+498.4% | -29.0M-205.3% | |
| Interest paid | 11.4M+8.2% | 10.6M-7.4% | 11.4M+86.8% | 6.11M+85.3% | 3.30M-49.6% | |
| Income taxes paid | 135M+67.0% | 80.6M+153.9% | 31.8M+95.7% | 16.2M+4426.4% | -375K-308.3% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 7.94B+34.9% | 5.89B+20.6% | 4.88B-36.5% | 7.69B+38.9% | 5.54B-4.2% | |
| P/E | 25.1×+89.0% | 13.3×-31.0% | 19.2×-47.2% | 36.4×+164.9% | 13.7×-69.3% | |
| P/S | 5.7×-1.9% | 5.8×-7.3% | 6.3×-52.8% | 13.3×+6.1% | 12.5×-42.2% | |
| P/B | 162.7×+905.4% | 16.2×-17.4% | 19.6×-75.3% | 79.3×+182.2% | 28.1×-26.5% | |
| P/FCF | 12.3×-2.0% | 12.6×-8.9% | 13.8×-57.4% | 32.4×+74.3% | 18.6×-83.0% | |
| Earnings yield | 4.0%-47.1% | 7.5%+45.0% | 5.2%+89.4% | 2.7%-62.3% | 7.3%+225.5% | |
| FCF yield | 8.1%+2.0% | 8.0%+9.8% | 7.2%+134.6% | 3.1%-42.6% | 5.4%+487.2% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: HALO’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all HALO filings on SEC EDGAR → Not investment advice.